SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-027760
Filing Date
2021-11-10
Accepted
2021-11-10 08:22:24
Documents
76
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1145260
2 ex31-1.htm EX-31.1 16236
3 ex31-2.htm EX-31.2 16909
4 ex32-1.htm EX-32.1 8963
  Complete submission text file 0001493152-21-027760.txt   6515344

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ghsi-20210930.xsd EX-101.SCH 51252
6 XBRL CALCULATION FILE ghsi-20210930_cal.xml EX-101.CAL 65422
7 XBRL DEFINITION FILE ghsi-20210930_def.xml EX-101.DEF 241738
8 XBRL LABEL FILE ghsi-20210930_lab.xml EX-101.LAB 448351
9 XBRL PRESENTATION FILE ghsi-20210930_pre.xml EX-101.PRE 356655
10 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1052803
Mailing Address 15150 AVENUE OF SCIENCE, SUITE 200 SAN DIEGO CA 92128
Business Address 15150 AVENUE OF SCIENCE, SUITE 200 SAN DIEGO CA 92128 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38861 | Film No.: 211394539
SIC: 2834 Pharmaceutical Preparations